Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Fortolin vs Panadol in Healthy Volunteers
NCT03562780Phase 1Completed
- Sponsor
- Fortune Pharmacal
- Start
- Nov 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of acetaminophen in pain and fever (2 arms), sponsored by Fortune Pharmacal. Primary endpoints: Peak drug concentration of paracetamol at 12 hours and Area under the drug plasma concentration-time curve of paracetamol at 12 hours. Started Nov 2018; status: completed.
02
Drugs
acetaminophen
03
Conditions
painfever
Beyond the preview
Go deeper on NCT03562780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03562780.